|
In the late 1990's Fabio Pammolli and Massimo Riccaboni begin publishing academic research on networks in bio-pharma industries. It becomes clear that the techniques and large databases they have developed may have commercial applications.
Focus: Economic research, bio-pharma, network dynamics.
|
In 2002 Pammolli and Riccaboni are joined by Sergio Dompé who provides the venture capital to create ATA S.p.A in order to deliver commercial consulting on these issues.
Focus: Commercial bio-pharma analysis, network dynamics.
ATA begins develop and extend internal software techniques for network data-mining of bio-pharma data in order to facilitate consulting projects. ATA begins providing reports to government and pharma companies in 2003.
Focus: pharma consulting, network dynamics, and specialized software.
It becomes clear that ATA's analytical techniques have broader application, so in 2004 work begins to adapt ATA's approach to a competitive intelligence model.
Focus: Bio-pharma consulting, network dynamics, business intelligence, and DyNet as a specialized tool for building patent and publication networks.
With the realization that the network data-mining software has much wider non-pharma applications, ATA begins development in 2005 of generalizable software architecture for adapting to clients needs and proprietary data.
Focus: Biopharma consulting, software structures for integrating databases, data-mining, and visualization of network dynamics.
|